Trial intelligence / Profile preview

Comparison of corticosteroid with botulinum toxin in treatment of chronic calcaneal spur

IRCT20190428043404N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Jan 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of neuronox in plantar fibroma and calcaneal spur (2 arms), sponsored by Iran University of Medical Sciences. Started Jan 2020; status: completed.

02

Drugs

neuronox
03

Conditions

plantar fibromacalcaneal spur

Beyond the preview

Go deeper on IRCT20190428043404N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190428043404N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call